Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 55.45 | 38.31 |
PEG Ratio (TTM) | 1.77 | -3.15 |
P/S Ratio (TTM) | 19.09 | 48.78 |
P/B Ratio (TTM) | 0.97 | 0.97 |
P/FCF Ratio (TTM) | N/A | 12.74 |
Price to 5YR AVG Earnings Ratio | N/A | 25.27 |
Price to 5YR AVG FCF Ratio | N/A | 26.58 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.66% | 2.00% |
ROE (TTM) | 1.80% | 6.43% |
Net Profit Margin (TTM) | 34.44% | 46.28% |
ROIC 5YR AVG | N/A | 8.54% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -9.56% | 596.30% | N/A |
Revenue | -4.47% | 459.91% | N/A |
Net Income | -9.26% | 564.05% | N/A |
Cash Flow | N/A | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.45 | 2.19 |
Quick Ratio (TTM) | 0.45 | 2.11 |
D/E Ratio (TTM) | 0.02 | 0.73 |
Interest Coverage (TTM) | -65.22 | 21.14 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | 11.02 | 7.90 |
LTL to 5YR AVG FCF | N/A | 9.01 |
Shares Outstanding Growth 5YR AVG | N/A | -1.70% |